Jade Biosciences, Inc.
Ticker: AVTE
| Insider | Title |
|---|---|
| Allison Dorval | Director |
| Asset Management, Lp Cormorant | Former 10% Owner |
| Benjamin T Dake | SEE REMARKS |
| Bihua Chen | Former 10% Owner |
| Capital Healthcare Fund Lp Ra | Director, 10% or greater ownership |
| Capital Management, L.p. Ra | Director, 10% or greater ownership |
| Capital Nexus Fund, L.p. Ra | Director |
| David S. Grayzel | Director |
| Donald J Santel | Director |
| George A Eldridge | SEE REMARKS |
| Global Healthcare Master Fund, Lp Cormorant | Former 10% Owner |
| Habib J Dable | Director |
| Hunter Gillies | CHIEF MEDICAL OFFICER |
| James Healy | 10% or greater ownership |
| Joshua Resnick | Director |
| Maha Katabi | Director, 10% or greater ownership |
| Management X, L.l.c. Sofinnova | 10% or greater ownership |
| Marinus Verwijs | CHIEF TECHNICAL OFFICER |
| Mark T Iwicki | Director |
| Peter Kolchinsky | Director, 10% or greater ownership |
| Private Healthcare Fund Ii, Lp Cormorant | Former 10% Owner |
| Rajeev M. Shah | Director, 10% or greater ownership |
| Ralph Niven | CHIEF SCIENTIFIC OFFICER |
| Timothy P Noyes | CHIEF EXECUTIVE OFFICER, Director |
| Timothy Pigot | CHIEF COMMERCIAL OFFICER |
| Venture Associates Xii, L.p. Atlas | 10% or greater ownership |
| Venture Associates Xii, Llc Atlas | 10% or greater ownership |
| Venture Fund Xii, L.p. Atlas | 10% or greater ownership |
| Venture Partners X, L.p. Sofinnova | 10% or greater ownership |